Gene associated with long-sightedness discovered down under

Article

Australia's Centre for Eye Research has discovered a hepatocyte growth factor (HGF) gene, which it hopes will provide important insights into biological mechanisms involved in ocular development.

Australia's Centre for Eye Research has discovered a hepatocyte growth factor (HGF) gene, which it hopes will provide important insights into biological mechanisms involved in ocular development.

The researchers believe that the HGF gene disrupts the emmetropisation process which leads to long-sightedness. The scientists examined DNA of 551 Australian adults. The study will be published in Ophthalmology and principal investigator, Professor Paul Baird said: “Currently the only treatments available for long-sightedness are glasses, contact lenses and laser techniques. We hope this important gene discovery will help us develop new drugs and I expect it will have a profound impact on improving global eye health.”

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.